share_log

藥明康德：翌日披露報表

WUXI APPTEC: Next Day Disclosure Return

香港交易所 ·  Apr 2 16:30
Summary by Futu AI
無錫藥明康德新藥開發股份有限公司於2024年3月8日至4月2日期間，透過上海證券交易所回購共計5,279,036股A股股份。根據香港聯合交易所有限公司證券上市規則，公司需披露已發行股本變動。該系列股份回購行動始於2024年3月11日，當日回購937,079股，並於4月2日結束，當日回購426,774股。回購價格介於RMB 46.54至RMB 57.32之間，而回購股份總數占公司於回購前已發行股份的百分比不超過0.02%。公司確認，所有回購活動均已獲董事會批准，並符合相關法律規定。股份回購後，公司於2024年4月2日的結存為2,546,260,847股。
無錫藥明康德新藥開發股份有限公司於2024年3月8日至4月2日期間，透過上海證券交易所回購共計5,279,036股A股股份。根據香港聯合交易所有限公司證券上市規則，公司需披露已發行股本變動。該系列股份回購行動始於2024年3月11日，當日回購937,079股，並於4月2日結束，當日回購426,774股。回購價格介於RMB 46.54至RMB 57.32之間，而回購股份總數占公司於回購前已發行股份的百分比不超過0.02%。公司確認，所有回購活動均已獲董事會批准，並符合相關法律規定。股份回購後，公司於2024年4月2日的結存為2,546,260,847股。
Wuxi Pharmaceutical Ming Kand New Drug Development Co., Ltd. repurchased a total of 5,279,036 A-shares through the Shanghai Stock Exchange between March 8 and April 2, 2024. Under the Listing Rules of the Hong Kong Stock Exchange Limited, companies are required to disclose changes in issued share capital. The share repurchase operation began on March 11, 2024, repurchased 937,079 shares on the same day and ended on April 2, with the repurchase of 426,774 shares on the same day. The repurchase price is between RMB 46.54 and RMB 57.32, and the total number of shares repurchased represents a percentage of the Company's shares issued prior to the repurchase not exceeding 0.02%. The Company confirms that all repurchases have been approved by the Board of Directors and comply with the relevant legal requirements. After the share repurchase, the company had a deposit of 2,546,260,847 shares on April 2, 2024.
Wuxi Pharmaceutical Ming Kand New Drug Development Co., Ltd. repurchased a total of 5,279,036 A-shares through the Shanghai Stock Exchange between March 8 and April 2, 2024. Under the Listing Rules of the Hong Kong Stock Exchange Limited, companies are required to disclose changes in issued share capital. The share repurchase operation began on March 11, 2024, repurchased 937,079 shares on the same day and ended on April 2, with the repurchase of 426,774 shares on the same day. The repurchase price is between RMB 46.54 and RMB 57.32, and the total number of shares repurchased represents a percentage of the Company's shares issued prior to the repurchase not exceeding 0.02%. The Company confirms that all repurchases have been approved by the Board of Directors and comply with the relevant legal requirements. After the share repurchase, the company had a deposit of 2,546,260,847 shares on April 2, 2024.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.